Back to Search
Start Over
142P The predictive biomarker for immune-related adverse events (irAEs) in patients with metastatic renal cell carcinoma treated with the combination therapy of nivolumab plus ipilimumab: Musashino study-irAE.
- Source :
-
Annals of Oncology . Nov2022 Suppl 9, Vol. 33, pS1488-S1488. 1p. - Publication Year :
- 2022
- Subjects :
- *DRUG side effects
*RENAL cell carcinoma
*NIVOLUMAB
*IPILIMUMAB
*BIOMARKERS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 160398087
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.10.177